US 12,318,611 B2
Treating lung disease with spinal cord stimulation
Stephen T. Pyles, Ocala, FL (US)
Assigned to Spiro Medical, Inc., Belleair Bluffs, FL (US)
Filed by Spiro Medical, Inc., Belleair Bluffs, FL (US)
Filed on Mar. 8, 2024, as Appl. No. 18/600,006.
Application 18/600,006 is a continuation of application No. 17/657,136, filed on Mar. 30, 2022, granted, now 11,957,907.
Claims priority of provisional application 63/240,155, filed on Sep. 2, 2021.
Claims priority of provisional application 63/168,702, filed on Mar. 31, 2021.
Prior Publication US 2024/0207611 A1, Jun. 27, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/3601 (2013.01) [A61N 1/0551 (2013.01); A61N 1/36062 (2017.08); A61N 1/36071 (2013.01); A61N 1/36171 (2013.01); A61N 1/36175 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A method of treating chronic obstructive pulmonary disease (COPD), the method comprising:
providing at least one lead having at least one contact;
connecting the at least one lead to a pulse generator;
programming the pulse generator to generate electrical signals for release by the at least one contact in a predetermined location of an epidural space to mitigate COPD symptoms, wherein the predetermined location is a posterior portion of the epidural space to provide dorsal spinal column and dorsal root ganglion stimulation between C7 to T5 vertebrae; and
providing a remote control having one or more input buttons, the one or more input buttons being selectable to activate a treatment protocol for mitigating the COPD symptoms, and to deactivate the treatment protocol.